New Trials Added to MTS Recently (July 2018)
Below are MBC trials that have been added to Metastatic Trial Search in the last month.
- Gedatolisib plus PTK7-ADC for Metastatic Triple Negative Breast Cancer
- NKTR-262 and NKTR-214 with or without Opdivo for Advanced TNBC (and Other) Cancers
- SGN-LIV1A and Keytruda for Advanced Triple Negative Breast Cancer
- Talazoparib for Advanced Breast (and Other) Cancer with BRCA1/2 or Other Genetic Changes
- Keytruda for Advanced Breast (and Other) Cancers in Women or Men with a BRCA1/2 Mutation
Hormone Receptor Positive (ER+ and/or PR+)
- Debio 1347 plus Faslodex for HR+ Metastatic Breast Cancer
- RAD140 for Postmenopausal Women With HR+ Advanced Breast Cancer
HER2 positive (HER2+)
Use Metastatic Trial Search to match to all metastatic breast cancer trials that are right for you.